ADMA Biologics
ADMA
ADMA
113 hedge funds and large institutions have $223M invested in ADMA Biologics in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more capital invested
Capital invested by funds: $189M → $223M (+$33.3M)
8% more funds holding
Funds holding: 105 → 113 (+8)
7.18% more ownership
Funds ownership: 53.54% → 60.72% (+7.2%)
Holders
113
Holding in Top 10
4
Calls
$1.47M
Puts
$607K
Top Buyers
| 1 | +$16.8M | |
| 2 | +$5.8M | |
| 3 | +$5.01M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.61M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.92M |
Top Sellers
| 1 | -$5.98M | |
| 2 | -$4.39M | |
| 3 | -$2.5M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.67M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.36M |